Provided by Tiger Trade Technology Pte. Ltd.

Myriad Genetics

3.36
+0.17005.33%
Pre-market: 3.600.2400+7.14%07:21 EDT
Volume:3.94M
Turnover:12.61M
Market Cap:321.22M
PE:-2.79
High:3.37
Open:3.14
Low:3.06
Close:3.19
52wk High:8.59
52wk Low:2.74
Shares:95.60M
Float Shares:79.40M
Volume Ratio:3.73
T/O Rate:4.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2031
EPS(LYR):-3.9514
ROE:-32.54%
ROA:-8.59%
PB:1.06
PE(LYR):-0.85

Loading ...

Myriad Genetics director Daniel Skovronsky resigns from board

Reuters
·
Jun 23

3 Penny Stocks With Market Caps Over $400M To Consider

Simply Wall St.
·
Jun 22

Living Longer Is Big Business. These Stocks Will Benefit. -- Barrons.com

Dow Jones
·
Jun 19

Myriad Genetics director Rashmi Kumar sells 15,000 shares worth $66,843

Reuters
·
Jun 10

Myriad Genetics Holds 2026 Annual Meeting and Approves Plans

TIPRANKS
·
Jun 05

Myriad Genetics shareholders approve 4 million-share increase to employee stock purchase plan

Reuters
·
Jun 05

Press Release: Myriad Genetics Names Raj Jampa as New Chief Technology Officer

Dow Jones
·
Jun 02

Myriad Genetics reports interim MONSTAR-SCREEN-3 data showing Precise MRD test prognostic value across cancers at ASCO 2026

Reuters
·
May 27

Myriad Genetics launches Prolaris + AI prostate cancer test combining genomics, digital pathology AI

Reuters
·
May 27

Myriad Genetics Launches Prolaris® + AI, the First Prostate Cancer Test to Combine Genomics and Digital Pathology Artificial Intelligence (AI)

THOMSON REUTERS
·
May 27

MindWalk Holdings Leads Our Trio Of Promising Penny Stocks

Simply Wall St.
·
May 23

Actress Jackie Tohn Got Results Nobody Wants But They May Have Saved Her Life

GlobeNewswire
·
May 15

Myriad Genetics Director Paul Bisaro acquires 7,500 shares for $27,637.50

Reuters
·
May 15

Myriad Genetics to join Goldman Sachs Global Healthcare Conference fireside chat

Reuters
·
May 08

Myriad Genetics price target lowered to $6 from $7 at TD Cowen

TIPRANKS
·
May 07

Myriad Genetics Bets on Growth Amid Profit Squeeze

TIPRANKS
·
May 07

Myriad Genetics Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
May 06

Piper Sandler Reaffirms Their Buy Rating on Myriad Genetics (MYGN)

TIPRANKS
·
May 06

Analysts Offer Insights on Healthcare Companies: Myriad Genetics (MYGN) and Dianthus Therapeutics (DNTH)

TIPRANKS
·
May 06

Analysts Offer Insights on Healthcare Companies: Myriad Genetics (MYGN) and Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF)

TIPRANKS
·
May 06